6-mercaptopurine pharmacokinetics after use of azathioprine in renal transplant recipients with intermediate or high thiopurine methyl transferase activity phenotype

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 11, 1998, Pages 1261-1266

  Escousse, A ^a,b   Guedon, F ^a   Mounie, J ^a   Rifle, G ^a   Mousson, C ^a   D'Athis, P ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE;

ADOLESCENT; ADULT; AGRANULOCYTOSIS; AREA UNDER THE CURVE; ARTICLE; CAUCASIAN; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE LEVEL; FEMALE; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SCHOOL CHILD;

EID: 0031730356     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb03343.x     Document Type: Article

References (22)

1. Bailey, D. G., Wilson, T. W., Johnson, G. E. (1975) A gas chromatographic method for measuring 6-mercaptopurine in serum. J. Chromatogr. 11: 305-311
2. Brooks, R. S., Dorr, R. T., Durie, B. G. M. (1982) Interactions of allopurinol with 6-mercaptopurine and azathioprine. Biomedicine 36: 217-222
3. Chan, G. L. C., Canafax, D. M., Johnson, C. A. (1987) The therapeutic use of azathioprine in renal transplantation. Pharmacotherapy 7: 165-167
4. Chan, G. L. C., Erdman, G. R., Gruber, S. A., Matas, A. J., Canafax, D. M. (1990) Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients. J. Clin. Pharmacol. 30: 358-363
5. Ding, T. L., Gamberatoglio, J. G., Amend, W. J. C., Birnbaum, J., (1980) Azathioprine (AZA) bioavailability and pharmacokinetics in kidney transplant patients. Clin. Pharmacol. Ther. 27: 250
6. Elion, G. B. (1967) Biochemistry and pharmacology of purine analogues. Fed. Proc. 26: 898-903
7. Endrenyi, L. E., Patel, M. (1991) A new sensitive graphical method for detecting deviations from the normal distribution of drug response: the NTV plot. Br. J. Clin. Pharmacol. 32: 159-166
8. Escousse, A., Rifle, G., Sgro, C., Mousson, C., Zanetta, G., Chevet, D. (1995): Azathioprine toxicity, 6-mercaptopurine bioavailability, and the 'poor' 6-thiopurine methy lator phenotype. Eur. J. Clin. Pharmacol. 48: 309-310
9. Finkle, J. M. (1967) A fluorimetric method for the estimation of 6-mercaptopurine in serum. Ann. Biochem. 21: 362-371
10. Jacqz-Aigrain, E., Bessa, E., Medard, Y., Mircheva, Y., Vilmer, E. (1994) Thiopurine methyltransferase activity in a French population: HPLC assay conditions and effects of drugs on inhibition. Br. J. Clin. Pharmacol. 38: 1-8
11. Lennart, L., Van Loon, J. A., Weinshilboum, R. M. (1989) Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin. Pharmacol. Ther. 46: 149-154
12. Lennart, L., Lilleyman, J. S., Van Loon, J. A., Weinshilboum, R. M. (1990) Genetic variations in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia. Lancet 336: 225-229
13. Lin, S. N., Jessup, K., Floyd, M., Wang, T. F., Van Boren, C. T. (1980) Quantification of plasma azathioprine and 6-mercaptopurine levels in renal transplant patients. Transplantation 29: 290-294
14. Maddoks, J. L. (1978) Clinical pharmacological observation on azathioprine in kidney transplant patients. Clin. Sci. Mol. Med. 55: 20P
15. Odlind, B., Hartvig, P., Lindstrom, B., Lonnerholm, G., Tufueson, G. (1986) Serum azathioprine and 6-mercaptopurine levels and immunosuppressive activity after azathioprine in uremic patients. Int. J. Immunopharmacol. 8: 1-11
16. Ohlman, S., Lafolie, P., Lindholm, A., Liliemark, J., Tyden, G., Peterson, C. (1993) Large inter-individual variability in bioavailability of azathioprine in renal transplant recipients. Clin. Transplant. 7: 65-70
17. Sauer, H., Hantke, U., Wilmans, W. (1988) Azathioprine lymphotoxicity: potential lethal damage by its imidazole derivatives. Drug Res. 38: 820-824
18. Schwartz, R. S., Eisner, A., Dameshek, W. (1959) The effect of 6-mercaptopurine on primary and secondary immune responses. J. Clin. Invest. 38: 1394-1403
19. Suhl, H., Koren, G., Whalen, C., Soldin, S., Ziporski, A., Greenberg, M. (1986) Pharmacokinetic determinants of 6-mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia. Clin. Pharmacol. Ther. 40: 604-609
20. Van Scoik, K. G., Johnson, C. A., Porter, W. R. (1985) The pharmacology and metabolism of the thiopurine drugs: 6-mercaptopurine and azathioprine. Drug Metab. Rev. 16: 157-174
21. Weinshilboum, R. M., Raymond, F. A., Pazmino, P. A. (1978) Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin. Chim. Acta 85: 323-333
22. Whalen, C. E., Tamary, H., Greenberg, M., Ziporski, A., Soldin, S. J. (1985) Analysis of 6-mercaptopurine in serum or plasma using high performance liquid chromatography. Ther. Drug Monit. 7: 315-320